As a member of the TRP superfamily, TRPM8 channel, changes in its expression level is involved in the etiology of prostate cancers and it seems to be one of the most promising potential drug target channels in the treatment of prostate cancers15. Here, TRPM8 is linked to prostate carcinoma.